These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22910967)

  • 1. ACP Journal Club: review: proton-pump inhibitors are associated with increased risk for Clostridium difficile infection.
    Koretz RL
    Ann Intern Med; 2012 Aug; 157(4):JC2-13. PubMed ID: 22910967
    [No Abstract]   [Full Text] [Related]  

  • 2. Host and pathogen factors for Clostridium difficile infection and colonization.
    Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
    N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proton pump inhibitors and infection risk].
    Palencia-Herrejón E; Sánchez B; Escobar I; Gómez-Lus ML
    Rev Esp Quimioter; 2011 Mar; 24(1):4-12. PubMed ID: 21412664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
    Choudhry MN; Soran H; Ziglam HM
    QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI.
    Aronow HD
    Ann Intern Med; 2010 Dec; 153(12):JC6-13. PubMed ID: 21173402
    [No Abstract]   [Full Text] [Related]  

  • 6. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.
    Naggie S; Miller BA; Zuzak KB; Pence BW; Mayo AJ; Nicholson BP; Kutty PK; McDonald LC; Woods CW
    Am J Med; 2011 Mar; 124(3):276.e1-7. PubMed ID: 21396512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACP Journal Club. Review: Fidaxomicin is better than vancomycin for Clostridium difficile recurrence.
    Pegues DA
    Ann Intern Med; 2012 Apr; 156(8):JC4-09. PubMed ID: 22508749
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACP Journal Club. Concurrent PPIs and antibiotics for incident C. difficile infection were associated with increased risk for recurrent infection.
    Fekete T
    Ann Intern Med; 2010 Oct; 153(8):JC4-12. PubMed ID: 20956696
    [No Abstract]   [Full Text] [Related]  

  • 13. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACP Journal Club. Proton-pump inhibitors were associated with reduced effectiveness of alendronate for preventing hip fractures.
    Ito K
    Ann Intern Med; 2011 Oct; 155(8):JC4-13. PubMed ID: 22007072
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI.
    Granger CB
    Ann Intern Med; 2009 Aug; 151(4):JC2-13. PubMed ID: 19687487
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
    Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
    Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
    Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.
    Yearsley KA; Gilby LJ; Ramadas AV; Kubiak EM; Fone DL; Allison MC
    Aliment Pharmacol Ther; 2006 Aug; 24(4):613-9. PubMed ID: 16907893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.